ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
James J. Morris
Amita Rastogi
Bernard J. Gersh
Hartzell V. Schaff
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, J. J.
Right arrow Articles by Schaff, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, J. J.
Right arrow Articles by Schaff, H. V.

Ann Thorac Surg 1994;58:1490-1498
© 1994 The Society of Thoracic Surgeons


Articles

Operation for ventricular tachyarrhythmias: Refining current treatment strategies

James J. Morris, MD*, Amita Rastogi, MD, Marshall S. Stanton, MD, Bernard J. Gersh, MD, Stephen C. Hammill, MD, Hartzell V. Schaff, MD

Divisions of Thoracic and Cardiovascular Surgery and Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota USA

Accepted for publication May 11, 1994.

* Address reprint requests to Dr Morris, Division of Thoracic and Cardiovascular Surgery, Mayo Clinic, 200 First St, SW, Rochester, MN 55905.

For many patients with ventricular tachyarrhythmias, the optimal choice of palliative or curative therapies is not yet well established. To refine optimal current treatment strategies, baseline patient characteristics were studied in relation to likelihood of successful outcome in 240 consecutive patients undergoing operation for treatment of ventricular tachyarrhythmias from 1981 to 1991. Indications for operation were sudden cardiac death or inducible ventricular tachyarrhythmias refractory to medical therapy (or both). Treatment was directed endocardial procedures in 77 patients (32%), other cardiac procedures in 57 patients (24%) (coronary artery bypass grafting in 94% and valve procedure in 14%, either with [35%] or without [65%] concomitant implantable cardioverter-defibrillator), and implantable cardioverter-defibrillator alone in 106 patients (44%). Overall 30-day operative mortality was 5% (70% confidence interval, 4%–7%) and 2-year survival was 74% (70% confidence interval, 71%–77%). Overall 2-year freedom from sudden cardiac death was 97% (70% confidence interval, 96%–98%) and was similar (p = not significant) for all treatment modalities. For each treatment modality, multivariate analysis identified independent risk factors for operative mortality and 2-year tachyarrhythmia recurrence, advanced angina and congestive heart failure New York Heart Association classes, and overall mortality. To characterize better the use and benefit of coronary artery bypass grafting, risk factors related to outcome also were identified for patients stratified according to absence (44 patients) or presence (119 patients) of coronary artery disease excluding patients treated by directed endocardial procedures. In non-coronary artery disease patients, operative mortality was 0%. In coronary artery disease patients, operative mortality was 6% (70% confidence interval 3%–9%) in 65 patients treated with implantable cardioverter defibrillator only, 3% (70% confidence interval, 0%–5%) in 37 patients treated with coronary artery bypass grafting, and 0% in 17 patients treated with implantable cardioverter-defibrillator and coronary artery bypass grafting. Criteria which discriminated coronary artery disease patients treated and not treated by coronary artery bypass grafting were identified. Based on these observations, a refinement of optimal treatment strategies is presented. Whereas all surgical therapies for ventricular tachyarrhythmia convey similar benefits in reducing sudden cardiac death in appropriately selected patients, overall successful outcome is highly dependent on effective treatment of coexistent cardiac disease, in particular, coronary artery disease.




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
U. O. von Oppell, D. Milne, A. Okreglicki, and R. N. Scott Millar
Surgery for ventricular tachycardia of left ventricular origin: risk factors for success and long-term outcome
Eur J Cardiothorac Surg, November 1, 2002; 22(5): 762 - 770.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.